Responding to CIDs and HIPAA Subpoenas in FCA Investigations
Minimizing Scope of Disclosure, Mitigating Risk of Inadvertent Disclosure, Protecting PHI
Recording of a 90-minute CLE webinar with Q&A
This CLE course will provide guidance to healthcare counsel on responding to Civil Investigative Demands (CIDs) and HIPAA subpoenas in healthcare fraud and False Claims Act (FCA) investigations. The panel will provide best practices for complying with CIDs and subpoenas while protecting patient information.
- CIDs and HIPAA subpoenas in healthcare fraud and FCA investigations
- Responding to CIDs
- Responding to HIPAA subpoenas
- Maintaining patient confidentiality
The panel will review these and other key issues:
- What risks do counsel to healthcare providers face when responding to CIDs and HIPAA subpoenas in fraud investigations?
- What are key considerations for counsel when developing a response strategy?
- What steps can counsel take to protect patient privacy and ensure HIPAA compliance when responding to CIDs and HIPAA subpoenas?
Lauren P. DeSantis-Then
Ms. DeSantis-Then has an extensive background defending government investigations. She has experience representing... | Read More
Ms. DeSantis-Then has an extensive background defending government investigations. She has experience representing private companies, associations and executives in civil and criminal investigations and against the U.S. DOJ, SEC, FTC, DOE, HHS, HIS, as well as various attorneys general and state regulatory and enforcement bodies. Ms. DeSantis-Then has conducted numerous internal investigations following the receipt of a subpoena or other notice of a government investigation in the areas of healthcare fraud and abuse, Anti-Kickback Statute, FCA violations, agency noncompliance determinations, among others.Close
Ingrid S. Martin
Ms. Martin’s practice is centered on the healthcare industry. Ms. Martin routinely handles all types of federal... | Read More
Ms. Martin’s practice is centered on the healthcare industry. Ms. Martin routinely handles all types of federal and state government investigations faced by medical professionals, healthcare entities and members of the pharmaceutical and medical device industry. These include investigations by the U.S. Department of Justice, the FDA, the DEA, and the Office of the Inspector General of Health and Human Services, among others.Close